Scopis GmbH, a Berlin, Germany-based medical technology company that develops surgical navigation systems for ENT, maxillofacial and neurosurgery, closed a Series A financing round of undisclosed amount.
Backers included new investors the VC Fonds Technologie Berlin managed by the IBB Beteiligungsgesellschaft mbH and the Falk Strascheg Holding (EXTOREL) as as well as existing shareholders High-Tech Gruenderfonds (HTGF) and Fraunhofer Society.
The company intends to use the funds to expand sales on a global scale.
Founded in 2010 by Bartosz Kosmecki, Scopis is specializing in the development and commercialization of clinical measuring systems for different medical fields of application in the minimally invasive surgery. The company, a spin-off from the Charité University Medical Department in Berlin and the Fraunhofer Society, recently presented a new surgical navigation system (The Scopis Hybrid Navigation) which combines optic and electromagnetic measuring technologies in one system and allows surgeons to take indication oriented decisions as to which technology would be more suitable for each intervention and provide the best assistance.
Scopis’ navigation products are currently being commercialized and used in clinical settings in over 20 countries.
FinSMEs
19/11/2013
Related News
13/10/2010: Scopis Receives Start-up Financing